Praluent: conduct to adopt in a context of supply tension

News Healthcare & Pharma Guidance

Date: 4th Sep, 2024 Source: French National Agency for the Safety of Medicines and Health Products (ANSM) Country: France Original Source

Brief

"On "04/09/2024", the French National Agency for the Safety of Medicines and Health Products (ANSM) issued an update regarding Praluent: conduct to adopt in a context of supply tension. The ANSM recommends that pharmacists can dispense two doses of 150 mg Praluent solution injectable without prior medical consultation when Praluent 300 mg is unavailable due to supply tensions."

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Praluent: conduct to adopt in a context of supply tension

Brief

French National Agency for the Safety of Medicines and Health Products (ANSM)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Praluent: conduct to adopt in a context of supply tension

Brief

French National Agency for the Safety of Medicines and Health Products (ANSM)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.